Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'NEOPLASIA TYPE 2B' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 64 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Ohyama, T; Sato, M; Murao, K; Kittaka, K; Namihira, H; Matsubara, S; Imachi, H; Yamauchi, K; Takahara, J
      A case of multiple endocrine neoplasia type 2B undiagnosed for many years despite its typical phenotype

      ENDOCRINE
    2. Rajan, I; Gestblom, C; Kapur, RP
      RETMen2B-transgene produces sympathoadrenal tumors but does not prevent intestinal aganglionosis in gdnf-/- or gfr alpha-1-/- mice

      PEDIATRIC AND DEVELOPMENTAL PATHOLOGY
    3. Sukumaran, M; Waxman, SG; Wood, JN; Pachnis, V
      Flanking regulatory sequences of the locus encoding the murine GDNF receptor, c-ret, directs Lac Z (beta-galactosidase) expression in developing somatosensory system

      DEVELOPMENTAL DYNAMICS
    4. Gimm, O; Dziema, H; Brown, J; Cuong, HV; Hinze, R; Dralle, H; Mulligan, LM; Eng, C
      Over-representation of a germline variant in the gene encoding RET co-receptor GFR alpha-1 but not GFR alpha-2 or GFR alpha-3 in cases with sporadic medullary thyroid carcinoma

      ONCOGENE
    5. Kurokawa, K; Iwashita, T; Murakami, H; Hayashi, H; Kawai, K; Takahashi, M
      Identification of SNT/FRS2 docking site on RET receptor tyrosine kinase and its role for signal transduction

      ONCOGENE
    6. Kalinin, VN; Amosenko, FA; Shabanov, MA; Lubchenko, LN; Hosch, SB; Garkavtseva, RF; Izbicki, JR
      Three novel mutations in the RET proto-oncogene

      JOURNAL OF MOLECULAR MEDICINE-JMM
    7. Nakata, S; Okugi, H; Saitoh, Y; Takahashi, H; Shimizu, K
      Multiple endocrine neoplasia type 2B

      INTERNATIONAL JOURNAL OF UROLOGY
    8. Takano, T; Miyauchi, A; Yoshida, H; Hasegawa, Y; Kuma, K; Amino, N
      Large-scale analysis of mutations in RET exon 16 in sporadic medullary thyroid carcinomas in Japan

      JAPANESE JOURNAL OF CANCER RESEARCH
    9. Blume-Jensen, P; Hunter, T
      Oncogenic kinase signalling

      NATURE
    10. Poteryaev, DA; Saarma, M
      The GDNF family: From neurotrophic factors to oncogenesis

      MOLECULAR BIOLOGY
    11. Kasprzak, L; Nolet, S; Gaboury, L; Pavia, C; Villabona, C; Rivera-Fillat, F; Oriola, J; Foulkes, WD
      Familial medullary thyroid carcinoma and prominent corneal nerves associated with the germline V804M and V778I mutations on the same allele of RET

      JOURNAL OF MEDICAL GENETICS
    12. Gomez, A; Wellbrock, C; Gutbrod, H; Dimitrijevic, N; Schartl, M
      Ligand-independent dimerization and activation of the oncogenic Xmrk receptor by two mutations in the extracellular domain

      JOURNAL OF BIOLOGICAL CHEMISTRY
    13. Lindahl, M; Poteryaev, D; Yu, LY; Arumae, U; Timmusk, T; Bongarzone, I; Aiello, A; Pierotti, MA; Airaksinen, MS; Saarma, M
      Human glial cell line-derived neurotrophic factor receptor alpha 4 is the receptor for persephin and is predominantly expressed in normal and malignant thyroid medullary cells

      JOURNAL OF BIOLOGICAL CHEMISTRY
    14. Truchot, F; Grezard, P; Wolf, F; Balme, B; Perrot, H
      Multiple idiopathic mucocutaneous neuromas: a new entity?

      BRITISH JOURNAL OF DERMATOLOGY
    15. Hayashi, Y; Iwashita, T; Murakamai, H; Kato, Y; Kawai, K; Kurokawa, K; Tohnai, I; Ueda, M; Takahashi, M
      Activation of BMK1 via tyrosine 1062 in RET by GDNF and MEN2A mutation

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    16. Phay, JE; Moley, JF; Lairmore, TC
      Multiple endocrine neoplasias

      SEMINARS IN SURGICAL ONCOLOGY
    17. Lee, NC; Norton, JA
      Multiple endocrine neoplasia type 2B - genetic basis and clinical expression

      SURGICAL ONCOLOGY-OXFORD
    18. Acton, DS; Velthuyzen, D; Lips, CJM; Hoppener, JWM
      Multiple endocrine neoplasia type 2B mutation in human RET oncogene induces medullary thyroid carcinoma in transgenic mice

      ONCOGENE
    19. Wells, SA; Franz, C
      Medullary carcinoma of the thyroid gland

      WORLD JOURNAL OF SURGERY
    20. Besset, V; Scott, RP; Ibanez, CF
      Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase

      JOURNAL OF BIOLOGICAL CHEMISTRY
    21. Califano, D; Rizzo, C; D'Alessio, A; Colucci-D'Amato, GL; Cali, G; Bartoli, PC; Santelli, G; Vecchio, G; de Franciscis, V
      Signaling through Ras is essential for ret oncogene-induced cell differentiation in PC12 cells

      JOURNAL OF BIOLOGICAL CHEMISTRY
    22. Sweetser, DA; Froelick, GJ; Matsumoto, AM; Kafer, KE; Marck, B; Palmiter, RD; Kapur, RP
      Ganglioneuromas and renal anomalies are induced by activated RETMEN2B in transgenic mice

      ONCOGENE
    23. Bongarzone, I; Vigano, E; Alberti, L; Mondellini, P; Uggeri, M; Pasini, B; Borrello, MG; Pierotti, MA
      The Glu632-Leu633 deletion in cysteine rich domain of Bet induces constitutive dimerization and alters the processing of the receptor protein

      ONCOGENE
    24. Chang, TJ; Wu, SL; Chang, TC; Huang, SH; Chang, TJ
      De novo RET proto oncogene mutation in a patient with multiple endocrine neoplasia type 2B

      JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
    25. Uchino, S; Noguchi, S; Yamashita, H; Sato, M; Adachi, M; Yamashita, H; Watanabe, S; Ohshima, A; Mitsuyama, S; Iwashita, T; Takahashi, M
      Somatic mutations in RET exons 12 and 15 in sporadic medullary thyroid carcinomas: Different spectrum of mutations in sporadic type from hereditary type

      JAPANESE JOURNAL OF CANCER RESEARCH
    26. Duerr, EM; Gimm, O; Neuberg, DS; Kum, JB; Clifford, SC; Toledo, SPA; Maher, ER; Dahia, PLM; Eng, C
      Differences in allelic distribution of two polymorphisms in the VHL-associated gene CUL2 in pheochromocytoma patients without somatic CUL2 mutations

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    27. Gimm, O; Greco, A; Hoang-Vu, C; Dralle, H; Pierotti, MA; Eng, C
      Mutation analysis reveals novel sequence variants in NTRK1 in sporadic human medullary thyroid carcinoma

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    28. Takano, T; Miyauchi, A; Matsuzuka, F; Liu, G; Higashiyama, T; Yokozawa, T; Kuma, K; Amino, N
      Preoperative diagnosis of medullary thyroid carcinoma by RT-PCR using RNA extracted from leftover cells within a needle used for fine needle aspiration biopsy

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    29. Murakami, H; Iwashita, T; Asai, N; Shimono, Y; Iwata, Y; Kawai, K; Takahashi, M
      Enhanced phosphatidylinositol 3-kinase activity and high phosphorylation state of its downstream signalling molecules mediated by Ret with the MEN 2Bmutation

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    30. Fitze, G; Schreiber, M; Kuhlisch, E; Schackert, HK; Roesner, D
      Association of RET protooncogene codon 45 polymorphism with Hirschsprung disease

      AMERICAN JOURNAL OF HUMAN GENETICS
    31. ROVIGATTI U; AFANASYEVA T; BRANDNER S; HAINFELLNER JA; KIESS M; MADDALENA A; MALIN G; RULICKE T; STEINBACH T; WEISSENBERGER J; AGUZZI A
      TRANSGENIC MICE AS RESEARCH TOOLS IN NEUROCARCINOGENESIS

      Journal of neurovirology
    32. MARSH DJ; ANDREW SD; LEAROYD DL; POJER R; ENG C; ROBINSON BG
      DELETION-INSERTION MUTATION ENCOMPASSING RET CODON-634 IS ASSOCIATED WITH MEDULLARY-THYROID CARCINOMA

      Human mutation
    33. MILLER DG; TIWARI R; PATHAK S; HOPWOOD VL; GILBERT F; HSU TC
      DNA-REPAIR AND MUTAGEN SENSITIVITY IN PATIENTS WITH TRIPLE PRIMARY CANCERS

      Cancer epidemiology, biomarkers & prevention
    34. SANTORO MM; PENENGO L; MINETTO M; ORECCHIA S; CILLI M; GAUDINO G
      POINT MUTATIONS IN THE TYROSINE KINASE DOMAIN RELEASE THE ONCOGENIC AND METASTATIC POTENTIAL OF THE RON RECEPTOR

      Oncogene
    35. CARSONWALTER EB; SMITH DP; PONDER BAJ; BAYLIN SB; NELKIN BD
      POSTTRANSCRIPTIONAL SILENCING OF RET OCCURS, BUT IS NOT REQUIRED, DURING RAF-1 MEDIATED DIFFERENTIATION OF MEDULLARY-THYROID CARCINOMA-CELLS

      Oncogene
    36. ENG C; MYERS SM; KOGON MD; SANICOLA M; HESSION C; CATE RL; MULLIGAN LM
      GENOMIC STRUCTURE AND CHROMOSOMAL LOCALIZATION OF THE HUMAN GDNFR-ALPHA GENE

      Oncogene
    37. BONGARZONE I; VIGANO E; ALBERTI L; BORRELLO MG; PASINI B; GRECO A; MONDELLINI P; SMITH DP; PONDER BAJ; ROMEO G; PIEROTTI MA
      FULL ACTIVATION OF MEN2B MUTANT RET BY AN ADDITIONAL MEN2A MUTATION OR BY LIGAND GDNF STIMULATION

      Oncogene
    38. KALININ V; FRILLING A
      27-BP DELETION IN THE RET PROTOONCOGENE AS A SOMATIC MUTATION ASSOCIATED WITH MEDULLARY-THYROID CARCINOMA

      Journal of molecular medicine
    39. Shan, L; Nakamura, M; Nakamura, Y; Utsunomiya, H; Shou, NH; Jiang, XH; Jing, XF; Yokoi, T; Kakudo, K
      Somatic mutations in the RET protooncogene in Japanese and Chinese sporadic medullary thyroid carcinomas

      JAPANESE JOURNAL OF CANCER RESEARCH
    40. YAMAMOTO Y; ISOBE Y; NISHIYAMA Y; TAKASHIMA H; OHKAWA M; KIHARA M; MATSUSAKA K; MIYAUCHI A; KOBAYASHI S; TANABE M
      I-131 MIBG IMAGING IN MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B

      Clinical nuclear medicine
    41. LEAROYD DL; TWIGG SM; ZEDENIUS JV; ROBINSON BG
      THE MOLECULAR-GENETICS OF ENDOCRINE TUMORS

      Journal of pediatric endocrinology & metabolism
    42. Attie-Bitach, T; Abitbol, M; Gerard, M; Delezoide, AL; Auge, J; Pelet, A; Amiel, J; Pachnis, V; Munnich, A; Lyonnet, S; Vekemans, M
      Expression of the RET proto-oncogene in human embryos

      AMERICAN JOURNAL OF MEDICAL GENETICS
    43. SHIMOTAKE T; KUBOTA Y; INOUE K; YANAGIHARA J; IWAI N
      ABSENCE OF RECTOANAL INHIBITORY REFLEX IN A CHILD WITH MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B

      Journal of pediatric surgery
    44. Eng, C; Marsh, DJ; Robinson, BG; Chow, CW; Patton, MA; Southey, MC; Venter, DJ; Ponder, BAJ; Milla, PJ; Smith, VV
      Germline RET codon 918 mutation in apparently isolated intestinal ganglioneuromatosis

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    45. HEUCKEROTH RO; LAMPE PA; JOHNSON EM; MILBRANDT J
      NEURTURIN AND GDNF PROMOTE PROLIFERATION AND SURVIVAL OF ENTERIC NEURON AND GLIAL PROGENITORS IN-VITRO

      Developmental biology (Print)
    46. Gomez, JM; Biarnes, J; Volpini, V; Marti, T
      Neuromas and prominent corneal nerves without MEN 2B

      ANNALES D ENDOCRINOLOGIE
    47. SERI M; YIN L; BARONE V; BOLINO A; CELLI I; BOCCIARDI R; PASINI B; CECCHERINI I; LERONE M; KRISTOFFERSSON U; LARSSON LT; CASASA JM; CASS DT; ABRAMOWICZ MJ; VANDERWINDEN JM; KRAVCENKIENE I; BARIC I; SILENGO M; MARTUCCIELLO G; ROMEO G
      FREQUENCY OF RET MUTATIONS IN LONG-SEGMENT AND SHORT-SEGMENT HIRSCHSPRUNG DISEASE

      Human mutation
    48. BOCCIARDI R; MOGRABI B; PASINI B; BORRELLO MG; PIEROTTI MA; BOURGET I; FISCHER S; ROMEO G; ROSSI B
      THE MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B POINT MUTATION SWITCHES THE SPECIFICITY OF THE RET TYROSINE KINASE TOWARDS CELLULAR SUBSTRATES THAT ARE SUSCEPTIBLE TO INTERACT WITH CRK AND NCK

      Oncogene
    49. SMITH DP; HOUGHTON C; PONDER BAJ
      GERMLINE MUTATION OF RET CODON-883 IN 2 CASES OF DE-NOVO MEN 2B

      Oncogene
    50. LORENZO MJ; GISH GD; HOUGHTON C; STONEHOUSE TJ; PAWSON T; PONDER BAJ; SMITH DP
      RET ALTERNATE SPLICING INFLUENCES THE INTERACTION OF ACTIVATED RET WITH THE SH2 AND PTB DOMAINS OF SHC, AND THE SH2 DOMAIN OF GRB2

      Oncogene
    51. KITAMURA Y; GOODFELLOW PJ; SHIMIZU K; NAGAHAMA M; ITO K; KITAGAWA W; AKASU H; TAKAMI H; TANAKA S; WELLS SA
      NOVEL GERMLINE RET PROTOONCOGENE MUTATIONS ASSOCIATED WITH MEDULLARY-THYROID CARCINOMA (MTC) - MUTATION ANALYSIS IN JAPANESE PATIENTS WITH MTC

      Oncogene
    52. BUGALHO MJ; FRADE JP; SANTOS JR; LIMBERT E; SOBRINHO L
      MOLECULAR ANALYSIS OF THE RET PROTOONCOGENE IN PATIENTS WITH SPORADICMEDULLARY-THYROID CARCINOMA - A NOVEL POINT MUTATION IN THE EXTRACELLULAR CYSTEINE-RICH DOMAIN

      European journal of endocrinology
    53. PLOUIN PF; CHATELLIER G; FOFOL I; CORVOL P
      TUMOR RECURRENCE AND HYPERTENSION PERSISTENCE AFTER SUCCESSFUL PHEOCHROMOCYTOMA OPERATION

      Hypertension
    54. HOFSTRA RMW; FATTORUSO O; QUADRO L; WU Y; LIBROIA A; VERGA U; COLANTUONI V; BUYS CHCM
      A NOVEL POINT MUTATION IN THE INTRACELLULAR DOMAIN OF THE RET PROTOONCOGENE IN A FAMILY WITH MEDULLARY-THYROID CARCINOMA

      The Journal of clinical endocrinology and metabolism
    55. PANDIT SD; OHARE T; DONISKELLER H; PIKE LJ
      FUNCTIONAL-CHARACTERIZATION OF AN EPIDERMAL GROWTH-FACTOR RECEPTOR RET CHIMERA

      The Journal of biological chemistry
    56. CIRAFICI AM; SALVATORE G; DEVITA G; CARLOMAGNO F; DATHAN NA; VISCONTI R; MELILLO RM; FUSCO A; SANTORO M
      ONLY THE SUBSTITUTION OF METHIONINE-918 WITH A THREONINE AND NOT WITHOTHER RESIDUES ACTIVATES RET TRANSFORMING POTENTIAL

      Endocrinology
    57. DAHIA PLM; TOLEDO SPA; MULLIGAN LM; MAHER ER; GROSSMAN AB; ENG C
      MUTATION ANALYSIS OF GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR (GDNF), A LIGAND FOR THE RET GDNF RECEPTOR-ALPHA COMPLEX, IN SPORADIC PHEOCHROMOCYTOMAS/

      Cancer research
    58. YIN L; SERI M; BARONE V; TOCCO T; SCARANARI M; ROMEO G
      PREVALENCE AND PARENTAL ORIGIN OF DE-NOVO RET MUTATIONS IN HIRSCHSPRUNGS-DISEASE

      European journal of human genetics
    59. ALEMI M; LUCAS SD; SALLSTROM JF; AKERSTROM G; WILANDER E
      A NOVEL DELETION IN THE RET PROTOONCOGENE FOUND IN SPORADIC MEDULLARY-THYROID CARCINOMA

      Anticancer research
    60. MORRISON PJ; NEVIN NC
      MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B (MUCOSAL NEUROMA SYNDROME, WAGENMANN-FROBOESE SYNDROME)

      Journal of Medical Genetics
    61. HOFSTRA RMW; STELWAGEN T; STULP RP; DEJONG D; HULSBEEK M; KAMSTEEG EJ; VANDENBERG A; LANDSVATER RM; VERMEY A; MOLENAAR WM; LIPS CJM; BUYS CHCM
      EXTENSIVE MUTATION SCANNING OF RET IN SPORADIC MEDULLARY-THYROID CARCINOMA AND OF RET AND VHL IN SPORADIC PHEOCHROMOCYTOMA REVEALS INVOLVEMENT OF THESE GENES IN ONLY A MINORITY OF CASES

      The Journal of clinical endocrinology and metabolism
    62. FINK M; WEINHAUSEL A; NIEDERLE B; HAAS OA
      DISTINCTION BETWEEN SPORADIC AND HEREDITARY MEDULLARY-THYROID CARCINOMA (MTC) BY MUTATION ANALYSIS OF THE RET PROTOONCOGENE

      International journal of cancer
    63. WILLIAMS GH; ROONEY S; THOMAS GA; CUMMINS G; WILLIAMS ED
      RET ACTIVATION IN ADULT AND CHILDHOOD PAPILLARY THYROID-CARCINOMA USING A REVERSE TRANSCRIPTASE-N-POLYMERASE CHAIN-REACTION APPROACH ON ARCHIVAL-NESTED MATERIAL

      British Journal of Cancer
    64. KOVACS CS; MASE RM; KOVACS K; NGUYEN GK; CHIK CL
      THYROID MEDULLARY CARCINOMA WITH THYROGLOBULIN IMMUNOREACTIVITY IN SPORADIC MULTIPLE ENDOCRINE NEOPLASIA TYPE 2-B

      Cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/10/20 alle ore 03:56:14